These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12107742)

  • 1. Vascular function, insulin resistance and fatty acids.
    Steinberg HO; Baron AD
    Diabetologia; 2002 May; 45(5):623-34. PubMed ID: 12107742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and vascular function.
    Baron AD
    J Diabetes Complications; 2002; 16(1):92-102. PubMed ID: 11872375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
    Steinberg HO; Chaker H; Leaming R; Johnson A; Brechtel G; Baron AD
    J Clin Invest; 1996 Jun; 97(11):2601-10. PubMed ID: 8647954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active role for the vasculature in the delivery of insulin to skeletal muscle.
    Vincent MA; Clerk LH; Rattigan S; Clark MG; Barrett EJ
    Clin Exp Pharmacol Physiol; 2005 Apr; 32(4):302-7. PubMed ID: 15810996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in the vasculature.
    Mather KJ; Steinberg HO; Baron AD
    J Clin Invest; 2013 Mar; 123(3):1003-4. PubMed ID: 23454764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture.
    King GL; Park K; Li Q
    Diabetes; 2016 Jun; 65(6):1462-71. PubMed ID: 27222390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster.
    Egan BM; Lu G; Greene EL
    Prostaglandins Leukot Essent Fatty Acids; 1999; 60(5-6):411-20. PubMed ID: 10471131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats.
    Bitar MS
    Horm Metab Res; 2001 Oct; 33(10):577-84. PubMed ID: 11607876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid metabolism in obesity and type 2 diabetes mellitus.
    Blaak EE
    Proc Nutr Soc; 2003 Aug; 62(3):753-60. PubMed ID: 14692611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and the vasculature--old actors, new roles.
    Baron AD
    J Investig Med; 1996 Oct; 44(8):406-12. PubMed ID: 8952221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired non-esterified fatty acid suppression is associated with endothelial dysfunction in insulin resistant subjects.
    Balletshofer BM; Rittig K; Volk A; Maerker E; Jacob S; Rett K; Häring H
    Horm Metab Res; 2001 Jul; 33(7):428-31. PubMed ID: 11507681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New concepts in extracellular signaling for insulin action: the single gateway hypothesis.
    Bergman RN
    Recent Prog Horm Res; 1997; 52():359-85; discussion 385-7. PubMed ID: 9238859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Vasculature in Prediabetes.
    Wasserman DH; Wang TJ; Brown NJ
    Circ Res; 2018 Apr; 122(8):1135-1150. PubMed ID: 29650631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endothelial dysfunction in diabetes mellitus.
    Pănuş C; Moţa M; Vladu D; Vanghelie L; Răducanu CL
    Rom J Intern Med; 2003; 41(1):27-33. PubMed ID: 15529582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus.
    Olefsky JM; Revers RR; Prince M; Henry RR; Garvey WT; Scarlett JA; Kolterman OG
    Adv Exp Med Biol; 1985; 189():176-205. PubMed ID: 3898763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature.
    Barrett EJ; Wang H; Upchurch CT; Liu Z
    Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E252-63. PubMed ID: 21610226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free fatty acids (FFA) and endothelial dysfunction; role of increased oxidative stress and inflammation. --to: Steinberg et al. (2002) Vascular function, insulin resistance and fatty acids.
    Tripathy D; Aljada A; Dandona P
    Diabetologia; 2003 Feb; 46(2):300-1. PubMed ID: 12627332
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
    Tack CJ; Ong MK; Lutterman JA; Smits P
    Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.